Par expands its partnership with Merck. (Roundup).(Par Pharmaceutical Inc., Merck KGaA)(Brief Article)

Chemical Market Reporter, April, 2002

Par Pharmaceutical Inc., a subsidiary of Pharmaceutical Resources Inc., has entered into an agreement to expand its product partnership with Merck KGaA. Par has licensed from Merck the exclusive rights to 11 generic pharmaceutical products under development. Sales of the 11 branded products total $7.8 billion.

Par will serve as exclusive US marketer and distributor of the products, and Merck will manufacture the products. Most of those products are expected to enter the US market between 2003 and 2006.